FDA Seeks Input on Food Export Certification Program

202-434-4100

Matrimonial Attorney
On Balance Search Consultants

Chief Operating Officer / Business Manager
On Balance Search Consultants

Legal Expert in Commercial & Real Estate Litigation / Property Dispute Speciali…
On Balance Search Consultants

Family/Matrimonial Law Attorney
On Balance Search Consultants

Litigation Paralegal
Greenberg Traurig

Litigation Attorney / Real Estate and Commercial Litigator
On Balance Search Consultants

Trusts & Estates Partner / Senior Attorney
On Balance Search Consultants

Trusts & Estates Attorney / Estate Planning Lawyer
On Balance Search Consultants

Litigation Legal Support Specialist
Greenberg Traurig

Commercial Real Estate Transactional Attorney / Real Estate Lawyer
On Balance Search Consultants

FDA Seeks Public Input on Experiences with Export Certification for Human Food Products

Thursday, November 7, 2024

Print Mail Download info_icon_img

Today, the U.S. Food and Drug Administration (FDA) has requested public input regarding its current approach managing FDA certification for the export of human food products.
Companies that export products from the US are often asked by foreign customers and/or governments to supply a certification for products regulated by FDA. FDA’s export certification provides an official statement concerning a product’s regulatory or marketing status, based on available information at the time of issuance. To assist US exporters, FDA provides necessary export certification in the form of certificates or export lists.
Through FDA’s Request for Information, the agency intends to gather input from all impacted stakeholders to help the Human Food Program (HFP) ensure it is considering the full range of perspectives when planning and resourcing changes and improvements to the export list component of the Export Certification Program. Specifically, FDA requests comments on the challenges and experiences related to meeting the listing requirements of other countries and FDA’s certification processes for export lists, including suggested approaches for implementing fees to offset the operational costs associated with maintaining a growing number of export lists and potential program enhancements.
FDA requests feedback by January 7, 2025.